F.D.A. Authorizes Novavax’s Covid-19 Vaccine, a Latecomer
The Food and Drug Administration on Wednesday authorized a Covid-19 vaccine developed by Novavax, a biotechnology company in Maryland that received significant federal funding to produce the shot. The vaccine will be a new option for Americans as vaccination rates stagnate. After two years of development, the vaccine has finally overcome manufacturing problems to become…
Details